+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastric Cancer Drugs Market 2025-2029- Product Image
Gastric Cancer Drugs Market 2025-2029- Product Image
New

Gastric Cancer Drugs Market 2025-2029

  • PDF Icon

    Report

  • 217 Pages
  • May 2025
  • Region: Global
  • TechNavio
  • ID: 5876740
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The gastric cancer drugs market is forecasted to grow by USD 26.03 billion during 2024-2029, accelerating at a CAGR of 20.6% during the forecast period. The report on the gastric cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness campaigns for gastric cancer, growing geriatric population globally, and increasing prevalence of gastric cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The gastric cancer drugs market is segmented as below:

By Route Of Administration

  • Injectable
  • Oral

By Distribution Channel

  • Offline
  • Online

By Drug Class

  • Chemotherapy drugs
  • Targeted therapy drugs
  • Immunotherapy drugs
  • Hormonal therapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increase in number of drug approvals and drug launches as one of the prime reasons driving the gastric cancer drugs market growth during the next few years. Also, strong pipeline of gastric cancer drugs and increasing research and development by companies will lead to sizable demand in the market.

The report on the gastric cancer drugs market covers the following areas:

  • Gastric Cancer Drugs Market sizing
  • Gastric Cancer Drugs Market forecast
  • Gastric Cancer Drugs Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastric cancer drugs market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Blueprint Medicines Corp., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celltrion Co. Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi SA, and Zydus Lifesciences Ltd. Also, the gastric cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Gastric Cancer Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Gastric Cancer Drugs Market 2019 - 2023 ($ million)
5.2 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Drug Class segment analysis 2019 - 2023
Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Gastric Cancer Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Route of Administration
8.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
8.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
8.3 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
8.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Offline - Market size and forecast 2024-2029
Chart on Offline - Market size and forecast 2024-2029 ($ million)
Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Chart on Offline - Year-over-year growth 2024-2029 (%)
Data Table on Offline - Year-over-year growth 2024-2029 (%)
9.4 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ million)
Data Table on Online - Market size and forecast 2024-2029 ($ million)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
Chart on Drug Class - Market share 2024-2029 (%)
Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
10.3 Chemotherapy drugs - Market size and forecast 2024-2029
Chart on Chemotherapy drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Chemotherapy drugs - Market size and forecast 2024-2029 ($ million)
Chart on Chemotherapy drugs - Year-over-year growth 2024-2029 (%)
Data Table on Chemotherapy drugs - Year-over-year growth 2024-2029 (%)
10.4 Targeted therapy drugs - Market size and forecast 2024-2029
Chart on Targeted therapy drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Targeted therapy drugs - Market size and forecast 2024-2029 ($ million)
Chart on Targeted therapy drugs - Year-over-year growth 2024-2029 (%)
Data Table on Targeted therapy drugs - Year-over-year growth 2024-2029 (%)
10.5 Immunotherapy drugs - Market size and forecast 2024-2029
Chart on Immunotherapy drugs - Market size and forecast 2024-2029 ($ million)
Data Table on Immunotherapy drugs - Market size and forecast 2024-2029 ($ million)
Chart on Immunotherapy drugs - Year-over-year growth 2024-2029 (%)
Data Table on Immunotherapy drugs - Year-over-year growth 2024-2029 (%)
10.6 Hormonal therapy - Market size and forecast 2024-2029
Chart on Hormonal therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Hormonal therapy - Market size and forecast 2024-2029 ($ million)
Chart on Hormonal therapy - Year-over-year growth 2024-2029 (%)
Data Table on Hormonal therapy - Year-over-year growth 2024-2029 (%)
10.7 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.9 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Mexico - Market size and forecast 2024-2029
Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Chart on Mexico - Year-over-year growth 2024-2029 (%)
Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
15.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.7 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
SWOT
15.9 Celltrion Co. Ltd.
Celltrion Co. Ltd. - Overview
Celltrion Co. Ltd. - Product / Service
Celltrion Co. Ltd. - Key offerings
SWOT
15.10 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.11 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
SWOT
15.12 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
15.13 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.14 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
15.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.17 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.18 Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. - Overview
Zydus Lifesciences Ltd. - Business segments
Zydus Lifesciences Ltd. - Key news
Zydus Lifesciences Ltd. - Key offerings
Zydus Lifesciences Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Gastric Cancer Drugs Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 39: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Route of Administration
Exhibits 41: Data Table on Comparison by Route of Administration
Exhibits 42: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 50: Market opportunity by Route of Administration ($ million)
Exhibits 51: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 52: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 53: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 54: Chart on Comparison by Distribution Channel
Exhibits 55: Data Table on Comparison by Distribution Channel
Exhibits 56: Chart on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits 57: Data Table on Offline - Market size and forecast 2024-2029 ($ million)
Exhibits 58: Chart on Offline - Year-over-year growth 2024-2029 (%)
Exhibits 59: Data Table on Offline - Year-over-year growth 2024-2029 (%)
Exhibits 60: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits 64: Market opportunity by Distribution Channel ($ million)
Exhibits 65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 66: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits 67: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits 68: Chart on Comparison by Drug Class
Exhibits 69: Data Table on Comparison by Drug Class
Exhibits 70: Chart on Chemotherapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Chemotherapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Chemotherapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Chemotherapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 74: Chart on Targeted therapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 75: Data Table on Targeted therapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 76: Chart on Targeted therapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 77: Data Table on Targeted therapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 78: Chart on Immunotherapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Immunotherapy drugs - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Immunotherapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Immunotherapy drugs - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Hormonal therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Hormonal therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Hormonal therapy - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Hormonal therapy - Year-over-year growth 2024-2029 (%)
Exhibits 86: Market opportunity by Drug Class ($ million)
Exhibits 87: Data Table on Market opportunity by Drug Class ($ million)
Exhibits 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 91: Chart on Geographic comparison
Exhibits 92: Data Table on Geographic comparison
Exhibits 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 149: Market opportunity By Geographical Landscape ($ million)
Exhibits 150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 151: Impact of drivers and challenges in 2024 and 2029
Exhibits 152: Overview on criticality of inputs and factors of differentiation
Exhibits 153: Overview on factors of disruption
Exhibits 154: Impact of key risks on business
Exhibits 155: Companies covered
Exhibits 156: Company ranking index
Exhibits 157: Matrix on companies position and classification
Exhibits 158: Amgen Inc. - Overview
Exhibits 159: Amgen Inc. - Product / Service
Exhibits 160: Amgen Inc. - Key news
Exhibits 161: Amgen Inc. - Key offerings
Exhibits 162: SWOT
Exhibits 163: AstraZeneca Plc - Overview
Exhibits 164: AstraZeneca Plc - Product / Service
Exhibits 165: AstraZeneca Plc - Key news
Exhibits 166: AstraZeneca Plc - Key offerings
Exhibits 167: SWOT
Exhibits 168: Biocon Ltd. - Overview
Exhibits 169: Biocon Ltd. - Business segments
Exhibits 170: Biocon Ltd. - Key offerings
Exhibits 171: Biocon Ltd. - Segment focus
Exhibits 172: SWOT
Exhibits 173: Boehringer Ingelheim International GmbH - Overview
Exhibits 174: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 175: Boehringer Ingelheim International GmbH - Key news
Exhibits 176: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 177: SWOT
Exhibits 178: Bristol Myers Squibb Co. - Overview
Exhibits 179: Bristol Myers Squibb Co. - Product / Service
Exhibits 180: Bristol Myers Squibb Co. - Key news
Exhibits 181: Bristol Myers Squibb Co. - Key offerings
Exhibits 182: SWOT
Exhibits 183: Celltrion Co. Ltd. - Overview
Exhibits 184: Celltrion Co. Ltd. - Product / Service
Exhibits 185: Celltrion Co. Ltd. - Key offerings
Exhibits 186: SWOT
Exhibits 187: Dr Reddys Laboratories Ltd. - Overview
Exhibits 188: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 189: Dr Reddys Laboratories Ltd. - Key news
Exhibits 190: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 191: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 192: SWOT
Exhibits 193: Eisai Co. Ltd. - Overview
Exhibits 194: Eisai Co. Ltd. - Business segments
Exhibits 195: Eisai Co. Ltd. - Key offerings
Exhibits 196: Eisai Co. Ltd. - Segment focus
Exhibits 197: SWOT
Exhibits 198: Eli Lilly and Co. - Overview
Exhibits 199: Eli Lilly and Co. - Product / Service
Exhibits 200: Eli Lilly and Co. - Key offerings
Exhibits 201: SWOT
Exhibits 202: F. Hoffmann La Roche Ltd. - Overview
Exhibits 203: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 204: F. Hoffmann La Roche Ltd. - Key news
Exhibits 205: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 206: F. Hoffmann La Roche Ltd. - Segment focus

Executive Summary

The following companies are recognized as the key players in the global gastric cancer drugs market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Blueprint Medicines Corp., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Celltrion Co. Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi SA, and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in number of drug approvals and drug launches."

According to the report, one of the major drivers for this market is the increasing awareness campaigns for gastric cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Biocon Ltd.
  • Blueprint Medicines Corp.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Celltrion Co. Ltd.
  • Dr Reddys Laboratories Ltd.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Gastric Cancer Market Report 2025 - Product Image

Gastric Cancer Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Gastric Cancer Drugs Market Report 2025 - Product Image

Gastric Cancer Drugs Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Gastric Cancer Drugs Market Report by Type, Route of Administration, End User, and Region 2025-2033 - Product Image

Gastric Cancer Drugs Market Report by Type, Route of Administration, End User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • 74 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.